Fund Holdings — Artia Global Partners LP

Total Portfolio Value:
$341.00M
Total Bought:
$164.04M
Total Sold:
$81.62M
Net Transaction:
+$82.42M
Notable People:
Onusa Nmn Chantanapongwanij, Artia Global Partners Gp Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)094,887+94,887$0$78.37M22.98%+$78.37M
Soleno Therapeutics Inc494,424498,473+4,049$22.22M$35.62M10.44%+$13.39M
Verona Pharma PlcADS255,318538,488+283,170$11.86M$34.19M10.03%+$22.33M
Intra-Cellular Therapies Inc219,719219,7190$18.35M$28.99M8.50%+$10.63M
Insmed Incorporated(INSM)167,939318,239+150,300$11.59M$24.28M7.12%+$12.68M
Merus N V463,840424,640-39,200$19.50M$17.87M5.24%-$1.63M
Protagonist Therapeutics Inc293,851333,851+40,000$11.34M$16.15M4.73%+$4.80M
Arcellx Inc
COMMON STOCK
229,785229,085-700$17.62M$15.03M4.41%-$2.59M
AstraZeneca PLCADR(AZN)190,752190,7520$12.50M$14.02M4.11%+$1.52M
Boston Scientific Corporation(BSX)0129,700+129,700$0$13.08M3.84%+$13.08M
Quest Diagnostics Incorporated(DGX)056,717+56,717$0$9.60M2.81%+$9.60M
Alnylam Pharmaceuticals, Inc.(ALNY)56,40028,600-27,800$13.27M$7.72M2.26%-$5.55M
argenx SEADR(ARGX)11,31111,3110$6.96M$6.69M1.96%-$261.7K
Nuvalent Inc204,04590,745-113,300$15.97M$6.44M1.89%-$9.54M
Scholar Rock Holding Corporation(SRRK)0172,185+172,185$0$5.54M1.62%+$5.54M
Revolution Medicines, Inc.(RVMD)284,190104,190-180,000$12.43M$3.68M1.08%-$8.75M
Rhythm Pharmaceuticals, Inc.(RYTM)50,00050,0000$2.80M$2.65M0.78%-$150.5K
Springworks Therapeutics Inc53,93053,9300$1.95M$2.38M0.70%+$431.4K
Viking Therapeutics, Inc.(VKTX)90,27990,2790$3.63M$2.18M0.64%-$1.45M
Viridian Therapeutics, Inc.(VRDN)100,000160,000+60,000$1.92M$2.16M0.63%+$239.8K
TG Therapeutics, Inc.(TGTX)54,51554,5150$1.64M$2.15M0.63%+$508.6K
Intuitive Surgical, Inc.(ISRG)03,500+3,500$0$1.73M0.51%+$1.73M
EyePoint, Inc.(EYPT)216,700316,700+100,000$1.61M$1.72M0.50%+$102.1K
Neurocrine Biosciences, Inc.(NBIX)45,00014,700-30,300$6.14M$1.63M0.48%-$4.52M
United Therapeutics Corporation(UTHR)05,000+5,000$0$1.54M0.45%+$1.54M
Xenon Pharmaceuticals Inc.(XENE)40,00040,0000$1.57M$1.34M0.39%-$226.0K
Ascendis Pharma A/SADR(ASND)7,4407,4400$1.02M$1.16M0.34%+$135.3K
Janux Therapeutics, Inc.(JANX)162,97638,100-124,876$8.73M$1.03M0.30%-$7.70M
Mereo BioPharma Group plcADS(MREO)421,359421,3590$1.47M$948.1K0.28%-$526.7K
Travere Therapeutics, Inc.(TVTX)030,900+30,900$0$553.7K0.16%+$553.7K
Centessa Pharmaceuticals PlcADS80,38035,226-45,154$1.35M$506.6K0.15%-$839.8K
Oruka Therapeutics, Inc.(ORKA)07,380+7,380$0$75.7K0.02%+$75.7K
Annexon, Inc.(ANNX)172,2260-172,226$883.5K$0—-$883.5K
Charles River Laboratories International, Inc.(CRL)6,3050-6,305$1.16M$0—-$1.16M
Crinetics Pharmaceuticals In45,7650-45,765$2.34M$0—-$2.34M
Enliven Therapeutics Inc102,9000-102,900$2.32M$0—-$2.32M
Newamsterdam Pharma Company
ORDINARY SHARES
54,2850-54,285$1.40M$0—-$1.40M
Novo Nordisk A/SADR(NVO)200,0000-200,000$17.20M$0—-$17.20M
Tarsus Pharmaceuticals, Inc.(TARS)20,8110-20,811$1.15M$0—-$1.15M
Tectonic Therapeutic, Inc.(TECX)16,6500-16,650$768.7K$0—-$768.7K
Vaxcyte, Inc.(PCVX)162,2550-162,255$13.28M$0—-$13.28M
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q1 2025 | TickerTrail